Clinical Trial Update: A Phase 1 Safety and Pharmacokinetics Study of AER 001 Administered as a Dry Powder in Asthmatic Subjects [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluated the safety and pharmacokinetics of AER 001 delivered as a dry powder in participants with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AER 001

Snippet

Sponsor: Aerovance, Inc. | Conditions: Asthma | Phase 1 | Status: COMPLETED